Pharmacia Bextra Will Test COX-2 Market; Valdecoxib Clears FDA Nov. 16

Pharmacia's Bextra (valdecoxib) launch will test the hypothesis that the recent slow-down in the growth of Celebrex reflects a traditional nonsteroidal anti-inflammatory drug product lifecycle